SCHEMBL6247641

SCHEMBL6247641

CCCc1c(OCCCCOc2cccc(C#N)c2)ccc(C(C)=O)c1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 13/20 0.68
CYSLTR1 Q9Y271 13/20 0.68
GRM2 Q14416 5/20 0.64
PPARG P37231 2/20 0.61
PPARD Q03181 2/20 0.61
PPARA Q07869 2/20 0.61
LMNA P02545 2/20 0.61
CYP1A2 P05177 1/20 0.61
MAPT P10636 1/20 0.61
CYP2C9 P11712 1/20 0.61
NFKB1 P19838 1/20 0.61
BLM P54132 1/20 0.61
MEN1 O00255 1/20 0.52
GLA P06280 1/20 0.52
CYP3A4 P08684 1/20 0.52
ALOX5 P09917 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
PTGS1 P23219 1/20 0.52
PTGS2 P35354 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6244992 0.87 GRM2 (0.72) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL10741151 0.85 CYSLTR1 (0.77) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL11047529 0.85 CYSLTR2 (0.71) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL6242750 0.85 GRM2 (0.69) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL6245951 0.84 GRM2 (0.60) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL10741914 0.84 GRM2 (0.74) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL10751332 0.83 CYSLTR1 (0.58) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL10553840 0.83 CYSLTR2 (0.71) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL3177635 0.82 CYSLTR1 (0.67) CYSLTR2CYSLTR1GRM2PPARGPPARD
SCHEMBL10732139 0.82 PPARG (0.60) CYSLTR2CYSLTR1GRM2PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288346-A1 Acetophenone potentiators of metabotropic glutamate receptors MERCK & CO., INC. 2005-12-29 US disclosed
EP-1556038-A2 ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merck & Co., Inc. (US) 2005-07-27 EP disclosed
WO-2004018386-A2 ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK & CO., INC. (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288346-A1 Acetophenone potentiators of metabotropic glutamate receptors GRM2, GRM1, GRIK2 CYSLTR2 357/4885CYSLTR1 429/4885GRM2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.